AN1 0.00% 0.8¢ anagenics limited

Ann: Cellmid Presents at World Congress for Hair Research, page-4

  1. 551 Posts.
    lightbulb Created with Sketch. 173
    Sounds like some day we'll see an "évolis med" that includes both the botanicals and the molecule inhibitors and is even more effective. And the current évolis already works.

    Anyway, it's good to know for a long term investor that more products, and even more effective products, are on the horizon. And the évolis brand is just getting started. I still see Cellmid's "blockchain potential", to borrow the cryptocurrency term.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.